1-4 of 4
Jason Smith
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Pharmacogenetic Approaches Identify ANTXR1 As a Potential Mediator of Response to Therapeutic NF-κB Inhibition in Diffuse Large B Cell Lymphoma

Soham D. Puvvada, MD, Cassandra L Love, Vladimir Grubor, PhD, Jenny Zhang, Jason Smith, Sandeep S. Dave, MD
Journal: Blood
Blood (2011) 118 (21): 234.
https://doi.org/10.1182/blood.V118.21.234.234
Published: 2011
Journal Articles

Upregulated JAK/STAT Signaling Represents a Major Mode of Resistance to HDAC Inhibition In Lymphoma and Provides a Rationale for Novel Combination Therapy

Jason Smith, Katherine J. Walsh, MD, Cassandra L Jacobs, MS, Qingquan Liu, PhD, Siyao Fan, Amee Patel, Sandeep Dave, MD
Journal: Blood
Blood (2010) 116 (21): 434.
https://doi.org/10.1182/blood.V116.21.434.434
Published: 2010
Journal Articles

Hedgehog Pathway Inhibition Is a Novel Therapeutic Approach in Lymphomas and Its Efficacy is Inversely Related to PI3 Kinase Inhibition

Katherine J. Walsh, MD, Siyao Fan, Amee Patel, Cassandra L Jacobs, MS, Jason Smith, Qingquan Liu, PhD, Sandeep Dave, MD
Journal: Blood
Blood (2010) 116 (21): 1848.
https://doi.org/10.1182/blood.V116.21.1848.1848
Published: 2010
Journal Articles

Selective IKKβ Inhibition of the NF-Kappab Pathway Is An Effective Therapeutic Strategy In Lymphomas

Soham D. Puvvada, MD, Jason Smith, Cassandra L Jacobs, MS, Sandeep Dave, MD
Journal: Blood
Blood (2010) 116 (21): 1849.
https://doi.org/10.1182/blood.V116.21.1849.1849
Published: 2010